Product Information
BETAMETHASONE VALER 0.12% FOAM is a generic product labeled by Xiromed LLC, priced at $0.6734 per GM under NDC 70700014120. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Apr 18, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.2 mg/g
Manufacturer
Xiromed LLCNDC
70700014120
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE VALERATEApproval Type
Generic (ANDA)
FDA Application
ANDA210639FDA Approved
4/18/2023
TE Code
AB
On Market Since
5/10/2023
Pharmacological Classes
Price Statistics
The NADAC for BETAMETHASONE VALER 0.12% FOAM has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 19.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6734 per GM |
|---|---|
| All-time high | $0.9861 (Dec 10, 2025) |
| All-time low | $0.5348 (Aug 21, 2024) |
| 52-week high | $0.9861 |
| 52-week low | $0.6734 |
| Median price | $0.6987 |
| Average price | $0.7107 |
| Largest weekly change | +27.6% (Sep 18, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Betamethasone Valerate Foam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETAMETHASONE VALER 0.12% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE VALER 0.12% FOAM, manufactured by Xiromed LLC, is $0.6734 per GM (NDC 70700014120), effective Sep 30, 2026.
How has the price of BETAMETHASONE VALER 0.12% FOAM changed over time?
Over the history we have for it, the NADAC for BETAMETHASONE VALER 0.12% FOAM has declined 19.8%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for BETAMETHASONE VALER 0.12% FOAM?
Since Apr 17, 2024, the NADAC for BETAMETHASONE VALER 0.12% FOAM has ranged from a low of $0.5348 (Aug 21, 2024) to a high of $0.9861 (Dec 10, 2025), with a median of $0.6987 per GM.
Are there cheaper alternatives to BETAMETHASONE VALER 0.12% FOAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BETAMETHASONE VALER 0.12% FOAM, is $0.6316 per GM — about 6% below BETAMETHASONE VALER 0.12% FOAM.
Who manufactures BETAMETHASONE VALER 0.12% FOAM?
BETAMETHASONE VALER 0.12% FOAM (NDC 70700014120) is labeled by Xiromed LLC, and CMS classifies it as a generic product.